Hendrée Jones E1, Stacey Klaman L2, Catherine Leiner3, Raquel da Silva Barros4, Roberto Canay5, Jesica Suarez V6, Rocio Suarez Ordoñez M7, Kevin O'Grady E8. 1. PhD, UNC Horizons, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, and Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205-2196 USA. 2. PhD, MPH, Postdoctoral Research Fellow, Laura Rodriguez Research Institute, Family Health Centers of San Diego, San Diego, CA. 3. BS, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC. 4. Founder, Lua Nova, Sao Paulo, Brazil. 5. PhD, e-Universidad del Museo Social Argentino (UMSA). Buenos Aires, Argentina. 6. MA, Psychologist, General Director of Social Policies in Addictions of Buenos Aires City, Buenos Aires, Argentina. 7. Research Department, Institute of Cognitive Neuroscience INECO, Oroño. 8. PhD, Department of Psychology, University of Maryland, College Park, MD 20742 USA.
Abstract
Background: Substance use during pregnancy and early parenting years is a well-known global public health problem, but the literature comparing treatment programs for this subpopulation across countries is limited. This article both describes three women-centered treatment programs in the United States, Brazil, and Argentina and examines similarities and differences among the programs in terms of patient characteristics. Such an analysis can better inform clinicians in the assessment and treatment of women who use substances and improve the universal understanding about them. Methods: A secondary data analysis of patient characteristics (e.g., pregnant at treatment admission) and patient history (e.g., substance dependence diagnosis, family history of substance use, co-occurring mental health issues) of reproductive age women (N=356) from substance use treatment programs in the United States, Brazil, and Argentina. Results: The Horizons program admitted the highest percentage of pregnant women (60%), Lua Nova (36%), and Casa Santa Clara (17%). Horizons patients (82%) were more likely to have a substance dependence diagnosis than Lua Nova (15%) or Casa Santa Clara patients (13%). Horizons patients (78%) were more likely to have a family history of substance use than Lua Nova (15%) or Casa Santa Clara (57%) patients. Horizons was also more likely than Lua Nova or Casa Santa Clara to have patients who had entered mental health treatment (70% vs. 19% vs. 9%, respectively). Conclusion: Substance use problems that continue during pregnancy and parenting are common within different cultures and societies. These analyses identified similarities and differences in patient characteristics, history, and treatment programs. Cross-cultural comparisons of treatment approaches provide opportunities for clinicians to explore new ways of caring for this population.
Background: Substance use during pregnancy and early parenting years is a well-known global public health problem, but the literature comparing treatment programs for this subpopulation across countries is limited. This article both describes three women-centered treatment programs in the United States, Brazil, and Argentina and examines similarities and differences among the programs in terms of patient characteristics. Such an analysis can better inform clinicians in the assessment and treatment of women who use substances and improve the universal understanding about them. Methods: A secondary data analysis of patient characteristics (e.g., pregnant at treatment admission) and patient history (e.g., substance dependence diagnosis, family history of substance use, co-occurring mental health issues) of reproductive age women (N=356) from substance use treatment programs in the United States, Brazil, and Argentina. Results: The Horizons program admitted the highest percentage of pregnant women (60%), Lua Nova (36%), and Casa Santa Clara (17%). Horizons patients (82%) were more likely to have a substance dependence diagnosis than Lua Nova (15%) or Casa Santa Clara patients (13%). Horizons patients (78%) were more likely to have a family history of substance use than Lua Nova (15%) or Casa Santa Clara (57%) patients. Horizons was also more likely than Lua Nova or Casa Santa Clara to have patients who had entered mental health treatment (70% vs. 19% vs. 9%, respectively). Conclusion: Substance use problems that continue during pregnancy and parenting are common within different cultures and societies. These analyses identified similarities and differences in patient characteristics, history, and treatment programs. Cross-cultural comparisons of treatment approaches provide opportunities for clinicians to explore new ways of caring for this population.
Entities:
Keywords:
Cross-cultural comparison; Pregnancy; Substance use treatment; Women
Authors: Jeffrey Ecker; Alfred Abuhamad; Washington Hill; Jennifer Bailit; Brian T Bateman; Vincenzo Berghella; Tiffany Blake-Lamb; Constance Guille; Ruth Landau; Howard Minkoff; Malavika Prabhu; Emily Rosenthal; Mishka Terplan; Tricia E Wright; Kimberly A Yonkers Journal: Am J Obstet Gynecol Date: 2019-03-27 Impact factor: 8.661
Authors: Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan Journal: MMWR Morb Mortal Wkly Rep Date: 2018-08-10 Impact factor: 17.586